Liby, K., Black, C. C., Royce, D. B., Williams, C. R., Risingsong, R., Yore, M. M., . . . Sporn, M. B. (2008). The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis.
استشهاد بنمط شيكاغوLiby, Karen, et al. The Rexinoid LG100268 and the Synthetic Triterpenoid CDDO-methyl Amide Are More Potent Than Erlotinib for Prevention of Mouse Lung Carcinogenesis. 2008.
MLA استشهادLiby, Karen, et al. The Rexinoid LG100268 and the Synthetic Triterpenoid CDDO-methyl Amide Are More Potent Than Erlotinib for Prevention of Mouse Lung Carcinogenesis. 2008.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.